Clinical trials recruiting in Mibu, Japan

Phase breakdown

Conditions recruiting in Mibu, Japan

Recruiting trials in Mibu, Japan

• A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
  NCT06389136 · Phase: Phase 3 · Ages: 18 Years to 63 Years · Sex: All (male and female)
• A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor
  NCT06241118 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female)
• An Observational Study to Assess Change in Disease Activity and Adverse Events in Adolescent and Adult Participants With Moderate to Severe Active Crohn's Disease (CD) in Japan
  NCT06023030 · Phase: Not specified · Ages: 15 Years and older · Sex: All (male and female)
• Study to Assess Change in Disease Activity of Risankizumab Treatment in Japanese Participants With Moderate to Severe Ulcerative Colitis
  NCT07136116 · Phase: Not specified · Ages: 15 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Mibu, Japan?

4 recruiting trials have at least one study site in Mibu, Japan.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.